| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5704838 | Journal Français d'Ophtalmologie | 2017 | 6 Pages |
Abstract
Transconjunctival BTX-A application is safe and effective for the treatment of eyelid retraction in dysthyroid orbitopathy. No difference was found between doses. No severe side effects were reported.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
A. Nava Castañeda, J.L. Tovilla Canales, L. Garnica Hayashi, A. Velasco y Levy,